Jody Lawrence

Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART)

Clive M. Gray, Jody Lawrence, Jonathan Schapiro et al. · The Journal of Immunology · 1999 · 268 citations · Full text

Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus

Jody Lawrence, Douglas L. Mayers, Katherine Huppler Hullsiek et al. · New England Journal of Medicine · 2003 · 265 citations · Full text

Human Immunodeficiency Virus Type 1 Protease Genotypes and In Vitro Protease Inhibitor Susceptibilities of Isolates from Individuals Who Were Switched to Other Protease Inhibitors after Long-Term Saquinavir Treatment

Mark A. Winters, Jonathan Schapiro, Jody Lawrence et al. · Journal of Virology · 1998 · 102 citations · Full text

Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers

Polina German, Sunil Parikh, Jody Lawrence et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 86 citations

A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)

J Michael Kilby, R. Pat Bucy, Donna Mildvan et al. · The Journal of Infectious Diseases · 2006 · 83 citations

Antiretroviral Therapy, Treatment And Prevention, Human Retrovirus +15